| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |